Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, Reduces the Risk of Cardiovascular and Renal Disease as Assessed by Steno Risk Engines in Adults With Type 1 Diabetes
Sotagliflozin
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, Reduces the Risk of Cardiovascular and Renal Disease as Assessed by Steno Risk Engines in Adults With Type 1 Diabetes ### Output: Sotagliflozin